
Journal of Medicinal Chemistry p. 1894 - 1897 (1994)
Update date:2022-08-02
Topics:
Laufer, Stefan A.
Augustin, Jan
Dannhardt, Gerd
Kiefer, Werner
A novel class of nonantioxidant dual inhibitors of both CO and 5-LO is described.The balance between the activity against CO and 5-LO can be shifted by modifying the substitution pattern of the phenyl moiety at the 6-position of the pyrrolizine ring.Structure-activity relationships are discussed.Compound 3e with a 4-Cl substituent (IC50 = 0.21 μM (CO); 0.18 μM (5-LO)) and 3n with a 4-OCH3 substituent (IC50 = 0.1 μM (CO); 0.24 μM (5-LO)) are the most potent and well-balanced dual inhibitors of both enzymes.The inhibition of CO was determined in a bovine thrombocyte intact cell assay and that of 5-LO using intact bovine PMNL.Compound 3e was also ivestigated in human cells.
View MoreBeijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
NanJing Rate Biochemicals CO., LTD
Contact:+86-25-84931986
Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
website:http://www.ringchemicals.com/
Contact:+1-416-493-6870
Address:Toronto, Canada
Contact:86-510-82853889
Address:Rm.3732, No.18-2,Yonghe Rd.,Wuxi,Jiangsu,214023,China
Zhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Doi:10.1021/jo00094a025
(1994)Doi:10.1039/d0cc04861e
(2020)Doi:10.1016/S0040-4039(00)73103-0
(1994)Doi:10.1007/s00706-017-2092-8
(2018)Doi:10.1021/ja8063292
(2008)Doi:10.1021/jo802184y
(2009)